Fundraising FoxYuva Bioscences
2 known investors
Find your way into Yuva Bioscences
Sign up to find every way you can get introduced to Yuva Bioscences
- Your email: who you already know at Yuva Bioscences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Yuva Bioscences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Yuva Biosciences develops and licenses Y100, a cosmetic active ingredient that enhances mitochondrial health to reduce visible signs of aging for use in skincare and haircare products.
Investors · 2
Related companies · 5
Ideaya BiosciencesIDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers. Its lead candidate, darovasertib, is in late-stage trials for uveal melanoma, with a pipeline spanning PKC inhibition, ADC+DDR combinations, the MTAP pathway, and KAT6/7 inhibition.
VedaBioVedaBio develops a molecular detection platform using CRISPR technology that enables rapid, accurate detection of multiple biological targets without the need for amplification. The platform serves research, diagnostics, and industrial applications across multiple markets.
ImvivabioA clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.
Huya Bioscience InternationalHUYABIO International develops novel biopharmaceutical products originating in China for global markets, working with biopharmaceutical, academic and commercial partners to advance drug candidates across all therapeutic areas. It maintains a large China-sourced compound portfolio and operates offices across the US, Japan, South Korea, Canada, Ireland and China.
Iovance BiotherapeuticsIovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.
Companies working in the same space as Yuva Bioscences.
Frequently asked questions
- What does Yuva Bioscences do?
- Yuva Biosciences develops and licenses Y100, a cosmetic active ingredient that enhances mitochondrial health to reduce visible signs of aging for use in skincare and haircare products.
- Who are Yuva Bioscences's investors?
- Yuva Bioscences's investors include TBD Angels, Western Technology Investment.